SCM
Soleus Capital Management’s Organogenesis Holdings ORGO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.2M | Sell |
12,343,351
-135,000
| -1% | -$494K | 2.99% | 9 |
|
|
2025
Q1 | $53.9M | Sell |
12,478,351
-6,525
| -0.1% | -$28.2K | 3.88% | 5 |
|
|
2024
Q4 | $40M | Buy |
12,484,876
+645,000
| +5% | +$2.06M | 2.51% | 10 |
|
|
2024
Q3 | $33.9M | Buy |
11,839,876
+320,922
| +3% | +$918K | 2.62% | 10 |
|
|
2024
Q2 | $32.3M | Buy |
11,518,954
+1,945,756
| +20% | +$5.45M | 2.84% | 9 |
|
|
2024
Q1 | $27.2M | Buy |
9,573,198
+610,198
| +7% | +$1.73M | 2.02% | 10 |
|
|
2023
Q4 | $36.7M | Sell |
8,963,000
-3,333,163
| -27% | -$13.6M | 4.07% | 6 |
|
|
2023
Q3 | $39.1M | Buy |
12,296,163
+568,100
| +5% | +$1.81M | 3.61% | 5 |
|
|
2023
Q2 | $38.9M | Buy |
11,728,063
+1,875,000
| +19% | +$6.23M | 4.33% | 5 |
|
|
2023
Q1 | $21M | Buy |
9,853,063
+2,490,000
| +34% | +$5.3M | 2.17% | 9 |
|
|
2022
Q4 | $19.8M | Buy |
7,363,063
+874,000
| +13% | +$2.35M | 2.84% | 10 |
|
|
2022
Q3 | $21M | Buy |
6,489,063
+1,202,896
| +23% | +$3.9M | 2.86% | 12 |
|
|
2022
Q2 | $25.8M | Buy |
5,286,167
+2,746,000
| +108% | +$13.4M | 4.02% | 3 |
|
|
2022
Q1 | $19.4M | Buy |
2,540,167
+541,080
| +27% | +$4.12M | 2.5% | 8 |
|
|
2021
Q4 | $18.5M | Buy |
1,999,087
+1,359,200
| +212% | +$12.6M | 1.85% | 18 |
|
|
2021
Q3 | $9.11M | Buy |
+639,887
| New | +$9.11M | 1.42% | 22 |
|